Medical management of acute bacterial sinusitis: Recommendations of a clinical advisory committee on pediatric and adult sinusitis

Annals of Otology, Rhinology and Laryngology

Volumn 109, Issue 5 III, 2000, Pages 2-20

  Gooch III, W Manford ^b   Reiner, Seth A ^b   Brook, Itzhak ^a   Jenkins, Stephen G ^b   Sher, Lawrence ^b   Pichichero, Michael E ^b   Yamauchi, Terry ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Amoxicillin; Amoxicillin clavulanate; Antibiotic resistance; Antimicrobials; Cephalosporin; Fluoroquinolone; Haemophilus influenzae; Moraxella catarrhalis; Sinusitis; Streptococcus pneumoniae; Trimethoprim sulfamethoxazole

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFDINIR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DECONGESTIVE AGENT; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PEDIAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SINUSITIS;

EID: 0342803642     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (130)

1. United States Department of Health and Human Services. National health survey. Prevalence of selected chronic conditions, United States, 1983-85. Hyattsville, Md: US Department of Health and Human Services, 1987.
2. Adelglass J, Jones TM, Ruoff G, Kahn J, Wiesinger B, Reilly-Gauvin K, et al. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 1998;18:1255-63.
3. Gooch WM III. Antibacterial management of acute and chronic sinusitis. Managed Care Interface 1999(February):92-4.
4. Kaliner MA, Osguthorpe JD, Fireman P, Anon J, Georgitis J, Davis M, et al. Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol 1997;99(suppl): S829-S848.
5. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995;113:104-9.
6. Ray NF, Baraniuk JN, Thamer M, Rinehart C, Gergen P, Kaliner M, et al. Healthcare expenditures for sinusitis in 1996. Contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103:408-14.
7. Conde MV, Williams JW, Witsell DL, Piccirillo JF. Management of a 35-year-old man with acute nasal and sinus complaints. JCOM 1998;5:63-76.
8. Lusk RP, Stankiewicz JA. Pediatric rhinosinusitis. In: Anon JB, ed. Report of the Rhinosinusitis Task Force Committee Meeting. Otolaryngol Head Neck Surg 1997;117(suppl):S53-S57.
9. Wald ER. Expanded role of group A streptococci in children with upper respiratory infections. Pediatr Infect Dis J 1999; 18:663-5.
10. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 1998;316:13-20.
11. Fagnan LJ. Acute sinusitis: a cost-effective approach to diagnosis and treatment. Am Fam Physician 1998;58:1795-802, 805-6.
12. Poole MD. A focus on acute sinusitis in adults: changes in disease management. Am J Med 1999;106(5A):38S-47S.
13. Zacharisen MC, Kelly KJ. Allergic and infectious pediatric sinusitis. Pediatr Ann 1998;27:759-66.
14. Simon MW. Treatment of acute sinusitis in childhood with ceftibuten. Clin Pediatr 1999;38:269-72.
15. Jones NS. Current concepts in the management of paediatric rhinosinusitis. J Laryngol Otol 1999;113:1-9.
16. Laurier C, Lachaine J, Ducharme M. Economic evaluation of antibacterials in the treatment of acute sinusitis. Pharmacoeconomics 1999;15:97-113.
17. National Center for Health Statistics. Vital and health statistics: current estimates from National Health Interview Survey No. 190. Washington, DC: US Department of Health and Human Services, 1994.
18. Benson V, Marano MA. Current estimates from the National Health Interview Survey, 1992. Vital Health Stat 1994; 189:1-269.
19. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
20. Mainous AG III, Hueston WJ, Clark JR. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Pract 1996;42:357-61.
21. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 1996;43:56-62.
22. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
23. Wang EEL, Einarson TR, Kelner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis 1999;29:155-60.
24. Schwartz B, Mainous AG, Marey SM. Why do physicians prescribe antibiotics for children with upper respiratory tract infections? JAMA 1998;279:881-2.
25. Chen RF. Antibiotics for children with upper respiratory tract infections [Letter]. JAMA 1998;280:1399.
26. Woolf SH. Antibiotics for children with upper respiratory tract infections [Letter]. JAMA 1998;280:1400.
27. Ober NS. Antibiotics for adult respiratory infections: clinical considerations and management pitfalls. Drug Benefit Trends 1998;10:10-6.
28. Ober NS. Developing a definition for appropriate antibiotic therapy - patient-, disease-, and drug-related factors. Drug Benefit Trends 1998;10:17-22.
29. O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Acute sinusitis: principles of judicious use of antimicrobial agents. Pediatrics 1998;101(suppl 1):174-7.
30. Clement PAR, Bluestone CD, Gordts F, Lusk R, Otten F, Goossens H, et al. Management of rhinosinusitis in children. Consensus Meeting, Brussels, Belgium, September 13, 1996. Arch Otolaryngol Head Neck Surg 1998;124:31-4.
31. Fireman P. Diagnosis of sinusitis in children. Emphasis on the history and physical examination. J Allergy Clin Immunol 1992;90:433-6.
32. Wald ER. Sinusitis in children. N Engl J Med 1992;326: 319-23.
33. Wald ER. Sinusitis. Pediatr Ann 1998;27:811-8.
34. Wald ER, Dashefsky B, Guerra N, Byers C. Frequency and severity of infections in day care. J Pediatr 1988;112:540-6.
35. Wald ER, Guerra N, Byers C. Frequency and severity of infections in day care: three-year follow-up. J Pediatr 1991;118: 509-14.
36. Willner A, Choi SS, Vexina LG, Lazar RH. Intranasal anatomic variations in pediatric sinusitis. Am J Rhinol 1997;11: 355-60.
37. Ahuja GS, Thompson J. What role for antibiotics in otitis media and sinusitis? Postgrad Med 1998;104:93-9, 103-4.
38. Brook I. Bacteriologic features of chronic sinusitis in children. JAMA 1981;246:967-9.
39. Otten FWA, Grote JJ. Treatment of chronic maxillary sinusitis in children. Int J Pediatr Otorhinolaryngol 1988;15:269-78.
40. Tinkleman DG, Silk HJ. Clinical and bacteriologic features of chronic sinusitis in children. Am J Dis Child 1989;143: 938-41.
41. Otten HW, Antvelink JB, Ruyter De Wildt H, Rietema SJ, Siemelink RJG, Hordijk GJ. Is antibiotic treatment of chronic sinusitis effective in children? Clin Otolaryngol 1994;19:215-7.
42. Shapiro NL, Pransky SM, Hartin M, Bradley JS. Documentation of the prevalence of penicillin-resistant Streptococcus pneumoniae isolated from the middle ear and sinus fluid of children undergoing tympanocentesis or sinus lavage. Ann Otol Rhinol Laryngol 1999;108:629-33.
43. Applebaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
44. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
45. Thornsberry C, Brown SD, Yee YC, Bouchillon S, Marler J, Rich T. Increasing penicillin resistance in Streptococcus pneumoniae in the US: effect on susceptibility to oral cephalosporins. Infect Med 1993;10(suppl):15-24.
46. Pikis A, Akram S, Donkersloot JA, Campos JM, Rodriguez WJ. Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area. Arch Pediatr Adolesc Med 1995;149:30-5.
47. Doern GV, Brueggemann AB, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
48. Cram DL Jr, Moore K, Adler K, Alles E, Lian J, Bannister K. California Streptococcus pneumoniae resistance project (CASPr): the extent and impact of resistance in a Medi-Cal population. California Pharmacist 1996(Winter):34-50.
49. Thornsberry C. Activity of selected antimicrobials against penicillin-resistant S pneumoniae isolates. Infect Med 1997;14 (suppl A):13-9.
50. Thornsberry C, Ogilvie P, Kahn J, Mauriz Y, and the Laboratory Investigator Group. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn Microbiol Infect Dis 1997;29:249-57.
51. Low DE, Desrosiers M, McSherry J, Garber G, Williams J Jr, Remy H, et al. A practical guide for the diagnosis and treatment of acute sinusitis. Can Med Assoc J 1997;156(suppl 6):S1-S14.
52. Wallace RJ Jr, Steingrube VA, Nash DR, Hollis DG, Flanagan C, Brown BA, et al. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B catarrhalis, M nonliquefaciens, and M lacunata. Antimicrob Agents Chemother 1989;33:1845-54.
53. Doern GV, Brueggemann AB, Pierce G. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance survey. Antimicrob Agents Chemother 1996;40:2884-6.
54. Doyle MG, Morrow AL, Van R, Pickering LK. Intermediate resistance of Streptococcus pneumoniae to penicillin in children in day-care centers. Pediatr Infect Dis J 1992;11:831-5.
55. Mainous AG III, Evans ME, Hueston WJ, Titlow WB, McCown LJ. Patterns of antibiotic-resistant Streptococcus pneumoniae in children in a day-care setting. J Fam Pract 1998;46: 142-6.
56. Arnold KE, Leggiardo RJ, Breiman RF, Lipman HB, Schwartz B, Appleton MA, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 1996;128:757-64.
57. Duchin JS, Breiman RF, Diamond A, Lipman H, Block S, Hedrick J, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50.
58. Boken DJ, Chartrand SA, Goering RV, Kruger R, Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995; 14:879-84.
59. Mason EO Jr, Kaplan SL. Penicillin-resistant pneumococci in the United States [Letter]. Pediatr Infect Dis J 1995;14: 1017-8.
60. Surveillance Data, Inc. Bacterial resistance tracking. August 1998/February 1999. Plymouth Meeting, Pa: Surveillance Data, Inc, 1999.
61. Brook I, Gober AE. Monthly changes in the rate of recovery of penicillin-resistant organisms from children. Pediatr Infect Dis J 1997;16:255-7.
62. Brook I. β-lactamase-producing bacteria recovered after clinical failures with various penicillin therapy. Arch Otolaryngol 1984;110:228-31.
63. Brook I, Gober AE. Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatr 1984;23: 338-41.
64. Tunér K, Nord CE. Emergence of beta-lactamase-producing anaerobic bacteria in the tonsils during penicillin treatment. Eur J Microbiol 1986;5:399-404.
65. Sanders CC, Nelson GE, Sanders WE Jr. Bacterial interference. IV. Epidemiological determinants of the antagonist activity of the normal flora against group A streptococci. Infect Immunol 1977;16:599-603.
66. Sprunt K, Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med 1968;68:579-90.
67. Brook I, Gober AE. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J Antimicrob Chemother 1998;41:489-92.
68. Brook I. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984;6:601-7.
69. Brook I, Yocum P, Frazier EH. Bacteriology and beta-lactamase activity in acute and chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1996;122:418-22.
70. Holleman DR Jr, Williams JW Jr, Simel DL. Usual care and outcomes in patients with sinus complaints and normal results of sinus roentgenography. Arch Fam Med 1995;4:246-51.
71. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988; 105:343-9.
72. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. In: Anon JB, ed. Report of the Rhinosinusitis Task Force Committee Meeting. Otolaryngol Head Neck Surg 1997;117(suppl): S1-S7.
73. Bamberger DM. Antimicrobial treatment of sinusitis. Semin Respir Infect 1991;6:77-84.
74. Dingle JH, Bodger GF, Jordan WS Jr. Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland Press: Case Western Reserve University, 1964:347.
75. Williams JW, Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 1992;117:705-10.
76. Little DR, Mann BL, Sherk DW. Factors influencing the clinical diagnosis of sinusitis. J Fam Pract 1998;46:147-52.
77. Hueston WJ, Eberlein C, Johnson D, Mainous AG III. Criteria used by clinicians to differentiate sinusitis from viral upper respiratory tract infection. J Fam Pract 1998;46:487-92.
78. Berg O, Carenfelt C, Rystedt G, Änggård A. Occurrence of asymptomatic sinusitis in common cold and other acute ENT infections. Rhinology 1986;24:223-5.
79. Lindbaek M, Hjortdahl P, Johnsen U. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med 1996;28:183-8.
80. Kankam CG, Sallis R. Acute sinusitis in adults: difficult to diagnose, essential to treat. Postgrad Med 1997;102:253-8.
81. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992;15(suppl 1):S62-S88.
82. Dowell SF, Schwartz B, Phillips WR. Appropriate use of antibiotics for URIs in children. Part I. Otitis media and acute sinusitis. Am Fam Physician 1998;58:1113-8.
83. Stewart MH, Siff JE, Cydulka RK. Evaluation of the patient with sore throat, earache, and sinusitis: an evidence based approach. Emerg Med Clin North Am 1999;17:153-87.
84. Gwaltney JM Jr, Phillis CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994;330:25-30.
85. The Institute for Clinical Systems Integration. Acute sinusitis in adults. Postgrad Med 1998;103:154-6, 159-60, 166-8.
86. Willet LR, Carson JL, Williams JW Jr. Current diagnosis and management of sinusitis. J Gen Intern Med 1994;9:38-45.
87. Williams JW Jr, Simel DL. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA 1993;270:1242-6.
88. de Bock GH, Dekker FW, Stolk J, Springer MP, Kievit J, van Houwelingen JC. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol 1997;50:881-90.
89. Gwaltney JM Jr. State-of-the-art: acute community-acquired sinusitis. Clin Infect Dis 1996;23:1209-23.
90. Douville L. Management of acute sinusitis. J Am Acad Nurse Pract 1995;7:407-11.
91. Stafford CT. The clinician's view of sinusitis. Otolaryngol Head Neck Surg 1990;103:870-4.
92. Clayman GL, Adams FL, Paugh DR, Koopmann CF Jr. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope 1991;101:234-9.
93. Lerner DN, Choi SS, Zalzal GH, Johnson DL. Intracranial complications of sinusitis in childhood. Ann Otol Rhinol Laryngol 1995;104:288-93.
94. Broberg T, Murr A, Fischbein N. Devastating complications of acute pediatric bacterial sinusitis. Otolaryngol Head Neck Surg 1999;120:575-9.
95. Aronovitz GH. Antimicrobial therapy of acute otitis media: review of treatment recommendations. Clin Ther 2000;22: 29-39.
96. Thornsberry C, Ogilvie PT, Holley HP Jr, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective US study. Antimicrob Agents Chemother 1999;43:2612-23.
97. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10.
98. Mason EO, Lamberth LB, Kershaw NL, Presser BLT, Zoe A, Ambrose PG. Streptococcus pneumoniae in the United States: in-vitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother (in press).
99. Marchant CD, Shurin PA, Turcyzk VA, Feinstein JC, Johnson CE, Wasikowski DE, et al. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatrics 1984;105:633-8.
100. Pichichero ME. Resistant respiratory pathogens and extended-spectrum antibiotics. Am Fam Physician 1995;52:1739-46.
101. Levy DG, Stergachis A, McFarland LV, Van Vorst K, Graham DJ, Johnson ES, et al. Antibiotic and Clostridium difficile diarrhea in the ambulatory care setting. Clin Ther 2000;22: 91-102.
102. Klein JO. History of macrolide use in pediatrics. Pediatr Infect Dis J 1997;16:427-31.
103. Dagan R, Johnson CE, McLinn S, Abughali N, Feris J, Leibovits E, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000;19:95-104.
104. Pichichero ME. Cefprozil and respiratory tract infections in children. Pediatr Infect Dis J 1998;17:S53-S54.
105. Guay DRP. Formulary management of macrolide antibiotics. Pharmacoeconomics 1995;8:491-512.
106. Lynch JP III, Martinez FJ. Antimicrobial resistance in Streptococcus pneumoniae: implications for treatment in the new century. Available at: http://www.medscape.com/Medscape/RespiratoryCare/Treatmentupdate/1999/tu02/ public/toc-tu02.html. Accessed February 2,2000.
107. Doern GV, Pfaller MA, Ervin ME, Brueggemann AB, Jones RN. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada - 1997 results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 1998;32:313-6.
108. Jones RN, Biedenbach DJ, Erwin ME, Beach ML, Pfaller MA. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H influenzae. J Clin Microbiol 1999;37:1999-2002.
109. Schmitz FJ, Verhoef J, Fluit AC. Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group. Int J Antimicrob Agents 1999;12: 311-7.
110. Balfour JA, Lamb HM. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs 2000;59:115-39.
111. Spector SL, Bernstein IL. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998;102 (suppl):S107-S144.
112. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997;16:680-95.
113. Klapan I, Cǔlig J, Orešković K, Matrapazovski M, Radošević S. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. Am J Otolaryngol 1999;20:7-11.
114. Werk LN, Bauchner H. Practical considerations when treating children with antimicrobials in the outpatient setting. Drugs 1998;55:779-90.
115. Polmar SH. The role of the immunologist in sinus disease. J Allergy Clin Immunol 1992;90:511-5.
116. Hardman JC, Limbird LE, Molinoff PB, Ruddon RW, Oilman AG. The pharmacologic basis of therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996.
117. Katcher ML. Cold, cough, and allergy medications: uses and abuses. Pediatr Rev 1996;17:12-7.
118. Zieger RS. Prospects for ancillary treatment of sinusitis in the 1990s. J Allergy Clin Immunol 1992;90:478-95.
119. Ober NS. Respiratory tract infections: consider the total cost of care. Drug Benefit Trends 1998;10:23-9.
120. Thompson D. The costs of antimicrobial treatment failure in acute otitis media. Am J Manag Care 1999;5:S1000-S1003.
121. Hoppe JE. Rational prescribing of antibacterials in ambulatory children. Pharmacoeconomics 1996;10:552-74.
122. Steele RW, Estrada B, Begue RE, Mirza A, Travillion D, Thomas M. A double-blind taste comparison of pediatric antibiotic suspensions. Clin Pediatr 1997(April):193-9.
123. Krouse JH, Krouse HJ. Patient use of traditional and complementary therapies in treating rhinosinusitis before consulting an otolaryngologist. Laryngoscope 1999;109:1223-7.
124. McAlister WH, Lusk R, Muntz HR. Comparison of plain radiographs and coronal CT scans in infants and children with recurrent sinusitis. AJR Am J Roentgenol 1989;153:1259-64.
125. Evans KL. Recognition and management of sinusitis. Drugs 1998;56:59-71.
126. Wald ER, Milmoe GJ, Bowen AD, Ledesma-Medina J, Salamon N, Bluestone CB. Acute maxillary sinusitis in children. N Engl J Med 1981;304:749-54.
127. Evans FO, Sydnor B, Moore WE, Moore GR, Manwaring JL, Brill AH, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975;293:735-9.
128. Lusk RP. Surgical management of chronic sinusitis. In: Lusk RP, ed. Pediatric sinusitis. New York, NY: Raven Press, 1992:77-125.
129. DeBenedictis FM, Bush A. Rhinosinusitis and asthma: epiphenomenon or causal association? Chest 1999;115:550-6.
130. Rachelefsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol 1999;82:296-305.